Advances in Diabetes and Endocrinology

According to the U.S. News & World Report, NewYork-Presbyterian is home to New York’s top ranked Diabetes & Endocrinology program.

The Centers for Diabetes Care at NewYork-Presbyterian take an active role in using innovative treatments and educating the public on how to prevent this chronic disease. They also address a wide range of metabolic and endocrine disorders, including primary hyperparathyroidism, osteoporosis, transplantation-related bone disease, and Paget's Disease. The Naomi Berrie Diabetes Center at NewYork-Presbyterian/Columbia University Irving Medical Center is one of three Diabetes Centers of Excellence in New York State and has been cited by the American Diabetes Association for its quality care.

image of Dr. Thomas J. Fahey, III

Exploring Novel Treatments for Thyroid Cancer

Under the direction of Dr. Thomas J. Fahey, III, researchers at Weill Cornell Medicine have identified the use of gene expression analysis to discriminate benign and malignant thyroid nodules.

image of Dr. Jennifer Kuo

Interventional Endocrinology: An Emerging Specialty

Doctors at NewYork-Presbyterian/Columbia are looking to interventional endocrinology, an emerging specialty that uses percutaneous, image-guided, less-invasive procedures to address endocrine disorders that offers an alternative to surgery.

image of Dr. Felicia A. Mendelsohn Curanaj

Managing the Challenges of Pregnancy and Diabetes

Physicians at Weill Cornell Medicine reviewed the diagnostic criteria for diabetes in pregnancy; types of therapies available to prevent hyperglycemia; and strategies for reaching inpatient glycemic targets during the peripartum period.

image of Dr. Judith Korner

Meeting the Pressing Need for Evidence-Based Obesity Care

Research is a key component of the Weight Control Center. Dr. Korner is the principal investigator of an NIH-funded study to understand the hormonal regulation of appetite and energy balance.

image of Dr. Magdalena M. Bogun

Pathways to Diabetes Prevention: It’s All Relative

We found that insulin production decreases long before a patient is actually diagnosed with type 1 diabetes. Now that we know that a reduction in insulin production begins earlier on, we can diagnose T1D earlier in patients with antibody screening. So the question became how do we reach these individuals.

image of Dr. Marcus D. Goncalves

Regulating Metabolism in the Setting of Cancer

Dr. Goncalves has developed a mouse model that recapitulates the cachexia syndrome as they seek interventions – either dietary or metabolic – to help prevent muscle wasting and fat loss.

Newsletters for Medical Professionals

2021 Issue 2

2021 Issue 1

2019 Issue 2

2019 Issue 1

2018 Issue 2

2018 Issue 1

2017 Issue 1

Spring/Summer 2016

Spring 2015

November/December 2014